Crossmark

Impact of adding carboplatin to docetaxel chemotherapy on testosterone levels and treatment outcomes in metastatic docetaxel-resistant prostate cancer

Crossref DOI link: https://doi.org/10.1038/s41598-025-04667-0

Published Online: 2025-06-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Atalan, Hejar

Morgan, Michael A.

Ivanyi, Philipp

Kappler, Paula

Heidel, Florian H.

Reuter, Christoph W. M.
Funding

Funding for this research was provided by:

Medizinische Hochschule Hannover (MHH)
License Information

Text and Data Mining valid from 2025-06-20

Version of Record valid from 2025-06-20
More Information

Article History

Received: 12 June 2024

Accepted: 28 May 2025

First Online: 20 June 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below